市場調查報告書
商品編碼
1190726
電泳設備和耗材市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)Electrophoresis Equipment and Supplies Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
在預測期內,電泳設備和耗材市場預計將以 4.9% 的複合年增長率增長。
COVID-19 大流行對電泳設備和耗材市場產生了重大的積極影響。 這主要是由於電泳在COVID-19診斷中的應用。 已經開發出新的 SARS-CoV-2 檢測方法,以提高 COVID-19 的檢測能力。 該方法是使用傳統的非實時熱循環儀、CDC RT-qPCR 協議中包含的一組引物目標和瓊脂糖凝膠電泳的兩步端點 RT-PCR 協議。 這種新技術已導致 COVID-19 在美國和歐洲等發達國家的廣泛診斷。 這對大流行期間的市場擴張做出了重大貢獻。
電泳主要用於分離和分析大分子,例如蛋白質、核酸、質粒、DNA、RNA,以及這些大分子的片段。 電泳包括幾種相關的分析技術,例如親和電泳、毛細管電泳、凝膠電泳、免疫電泳、電印跡、脈衝場凝膠電泳和等電聚焦。
全球對醫療保健創新的需求正在增長。 COVID-19 迫使製藥和生物技術行業開發創新藥物和疫苗來對抗這種新病毒。 為此,製藥領域的技術革新不斷推進,而電泳在這些技術革新中扮演著重要的角色。 例如,2021 年 7 月發布的 PubMed 數據表明電泳在藥物開發中的應用越來越多。 研究人員使用電泳技術分析藥物。 因此,由於電泳在新藥開發中的應用越來越廣泛,預計研究市場在預測期內將出現強勁增長。
然而,電泳法的分析時間長是抑制市場增長的因素之一。
毛細管凝膠電泳技術用於製藥和生物技術行業,以分離質荷比隨大小變化不大的大分子,例如 DNA、RNA 和蛋白質。 2021 年,在英國,醫學研究慈善協會 (AMRC) 將為非工業研發支出貢獻 15 億英鎊(18.2 億美元),衛生與公共服務部 (DHSC) 將貢獻約 1 英鎊50 億美元(60 億美元)。8000 萬美元)。 增加對生命科學研究的投資,以及英國政府到 2027 年將研發支出提高到 GDP 的 2.4% 和長期 GDP 的 3% 的雄心也在推動市場的增長。
電泳設備和耗材市場由製藥和生物技術公司主導。 隨著電泳在質量控制中越來越多地被採用,例如藥物製劑中藥物含量的分析、DNA 片段的鑑定和研究以及抗生素和疫苗的測試,預計在預測期內會出現類似的趨勢。 例如,在 2022 年 8 月,Kymos 表示,各種類型和格式的電泳分析現在作為測試方法包含在其用於治療性蛋白質批量測試的分析證書中。 細胞因子、血液因子、激素、單克隆抗體 (mAb)、融合蛋白等是一些可以通過電泳分析的蛋白質。 隨著電泳重要性的增加,採用率也在增加,從而促進了該領域的發展。
醫療和保健領域的持續技術進步、對創新療法和藥物的需求不斷增加以及涉及基因、蛋白質和生物分子的研究項目不斷增加是製藥和生物技術公司細分市場的主要驅動力。是一個因素。
北美是電泳設備和耗材市場的主要參與者,原因是涉及蛋白質、基因和相關生物分子的研發項目需求增加,該地區與製藥質量控制相關的嚴格監管問題,以及工藝驗證流程。預計佔據市場份額。
美國不斷增加的投資和研發支出正在促進電泳設備市場的增長。 例如,根據美國國立衛生研究院數據2022,美國的研發投資從2016年的457億美元增加到2021年的886億美元。 因此,隨著美國各地研發成本的上升,預計未來幾年電泳設備和耗材市場將出現強勁增長。
要自信地鑑定和量化細胞和組織中表達的蛋白質、翻譯後修飾和蛋白質複合物,需要具有高分離效率和靈敏度的強大分析方法。 近年來,由於美國和其他發達國家的這種需求,人們對毛細管電泳-質譜 (CE-MS) 的興趣顯著增長。 隨著需求的增加,預計市場將在預測期內經歷強勁增長。
電泳設備和耗材市場是分散的,由幾家主要參與者組成。 從市場份額的角度來看,一些主要參與者目前主導著市場。 目前主導市場的公司有 Bio-Rad Laboratories, Inc、GE Healthcare、Thermo Fisher Scientific Inc、Agilent Technologies, Inc、Merck Millipore (Merck &Co., Inc.)、PerkinElmer, Inc、QIAGEN N.V.、Lonza Group Ltd、Shimadzu株式會社、Sebia集團等
The electrophoresis equipment and supplies market is expected to register a CAGR of 4.9% during the forecast period.
The COVID-19 pandemic had a significant positive impact on the electrophoresis equipment and supplies market. This is majorly due to the application of electrophoresis in diagnosing COVID-19. To increase COVID-19 testing capacities, a new method for SARS-CoV-2 detection was developed. The method includes using a two steps end point RT-PCR protocol, where conventional nonreal-time thermal cycler, the set of primers targets included on the CDC RT-qPCR protocol, and agarose gel electrophoresis are used. With the help of this new method, the diagnosis of COVID-19 was widely made across developed countries, such as United States and European countries. This factor contributed significantly to market growth during the pandemic.
The electrophoresis technique is mainly used to separate and analyze large molecules, such as proteins, nucleic acids, plasmids, DNA, RNA, and fragments of these macromolecules. Electrophoresis comprises several related analytical techniques, such as affinity electrophoresis, capillary electrophoresis, gel electrophoresis, immune electrophoresis, electroblotting, pulsed-field gel electrophoresis, and isoelectric focusing.
The demand for healthcare innovations has been increasing worldwide. COVID-19 forced the pharmaceutical and biotechnology industries to develop innovative drugs or vaccines that can cope with the novel virus. This led to increasing innovations in the field of pharmaceuticals, and electrophoresis plays a crucial role in these innovations. For instance, the PubMed data published in July 2021 suggests that the application of electrophoresis is on the rise in pharmaceutical development. Researchers use the electrophoresis technique for pharmaceutical analysis. Hence, with the rising use of electrophoresis in new drug development, the market studied is expected to witness strong growth over the forecast period.
However, the long analysis time associated with this technique is one of the factors hindering the market growth.
Capillary gel electrophoresis techniques are used in pharmaceutical and biotechnology industries to separate large molecules or macromolecules, such as DNA, RNA, and proteins, whose mass-to-charge ratios do not vary much with size. In 2021, the Association of Medical Research Charities (AMRC) contributed GBP 1.5 billion (USD 1.82 billion) of non-industry spending on research and development in United Kingdom, while the Department of Health and Social Care (DHSC) spent around GBP 5 billion (USD 6.08 billion). Increasing investments in life sciences research and the United Kingdom government's ambition to increase R&D spending to 2.4% of GDP by 2027 and 3% over the longer term also support market growth.
The pharmaceutical and biotechnology companies segment holds a significant market share in the electrophoresis equipment and supplies market. It is anticipated to show a similar trend over the forecast period due to the growing adoption of electrophoresis in quality control of pharmaceutical formulations by analyzing the drug content of pharmaceutical formulations and identification and study of DNA fragments, and testing of antibiotics and vaccines. For instance, in August 2022, Kymos stated that electrophoretic assays in different types and formats are currently included as a testing method in the certificates of analysis for batch testing of therapeutic proteins. Cytokines, blood factors, hormones, monoclonal antibodies (mAbs), and fusion proteins are some of the proteins that can be analyzed with electrophoresis. The adoption of electrophoresis increases with its rising importance, which contributes to the growth of the segment.
Constant technological advancements in the medical and healthcare sector, the growing demand for innovative therapies and drugs, and increasing research projects on genes, proteins, and biomolecules are the key factors driving the pharmaceutical and biotechnology companies segment.
North America is expected to hold a major market share in the electrophoresis equipment and supplies market due to growing demand from research and development projects involving proteins, genes, and associated biomolecules, stringent regulatory issues on pharmaceutical product quality control, and process validation processes in this region.
Increasing investments and R&D spending in United States contributes to the growth of the electrophoresis equipment market. For instance, according to the National Institute of Health data 2022, R&D investments in United States increased to USD 88.6 billion in 2021 from USD 45.7 billion in 2016. Hence, with the rise in R&D expenditure across United States, the market for electrophoresis equipment and supplies is expected to witness strong growth in the coming years.
Strong analytical methods with high separation efficiency and sensitivity are needed to confidently identify and quantify proteins, posttranslational modifications, and protein complexes expressed in cells and tissues. In recent years, interest in capillary electrophoresis-mass spectrometry (CE-MS) greatly expanded due to this demand in developed countries like United States. With the increasing demand, the market studied is believed to witness strong growth over the forecast period.
The electrophoresis equipment and supplies market is fragmented and consists of several major players. In terms of market share, a few major players currently dominate the market. Some companies that currently dominate the market are Bio-Rad Laboratories, Inc, GE Healthcare, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Merck Millipore (Merck & Co., Inc.), PerkinElmer, Inc., QIAGEN N.V., Lonza Group Ltd, Shimadzu Corporation, and Sebia Group.